XML 19 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
Discontinued Operations
9 Months Ended
Oct. 01, 2017
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations
Disposition of Businesses and Assets

As part of the Company’s continuing efforts to focus on higher growth opportunities, the Company has discontinued certain businesses. When the discontinued operations represent a strategic shift that will have a major effect on the Company's operations and financial statements, the Company has accounted for these businesses as discontinued operations and accordingly, has presented the results of operations and related cash flows as discontinued operations. Any business deemed to be a discontinued operation prior to the adoption of ASU 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of An Entity, continues to be reported as a discontinued operation, and the results of operations and related cash flows are presented as discontinued operations for all periods presented. Any remaining assets and liabilities of these businesses have been presented separately, and are reflected within assets and liabilities of discontinued operations in the accompanying condensed consolidated balance sheets as of October 1, 2017 and January 1, 2017.
On May 1, 2017 (the "Closing Date"), the Company completed the sale of its Medical Imaging business to Varex Imaging Corporation ("Varex") pursuant to the terms of the Master Purchase and Sale Agreement, dated December 21, 2016 (the “Agreement”), by and between the Company and Varian Medical Systems, Inc. ("Varian") and the subsequent Assignment and Assumption Agreement, dated January 27, 2017, between Varian and Varex, pursuant to which Varian assigned its rights under the Agreement to Varex. On the Closing Date, the Company received consideration of approximately $277.4 million for the sale of the Medical Imaging business. During the third quarter of fiscal year 2017, the Company paid Varex $4.2 million to settle the post-closing working capital adjustment. During the nine months ended October 1, 2017, the Company recorded a pre-tax gain of $180.4 million and income tax expense of $42.2 million related to the sale of the Medical Imaging business in discontinued operations and dispositions. The corresponding tax liability was recorded within the other tax liabilities in the condensed consolidated balance sheet, and the Company expects to utilize tax attributes to minimize the tax liability.
Following the closing, the Company is providing certain customary transitional services during a period of up to 12 months. Commercial transactions between the parties following the closing of the transaction are not expected to be significant.
Beginning in the fourth quarter of fiscal year 2016, the Company presented its Medical Imaging business as discontinued operations in the Company's consolidated financial statements. Financial information in this report relating to the three and nine months ended October 2, 2016 has been retrospectively adjusted to reflect this discontinued operation. The results of discontinued operations during the three and nine months ended October 1, 2017 include the results of the Medical Imaging business through April 30, 2017.
The summary pre-tax operating results of the discontinued operations were as follows for the three and nine months ended:
 
Three Months Ended
 
Nine Months Ended
 
October 1,
2017
 
October 2,
2016
 
October 1,
2017
 
October 2,
2016
 
(In thousands)
Revenue
$

 
$
33,635

 
$
44,343

 
$
110,859

Cost of revenue

 
21,386

 
32,933

 
71,870

Selling, general and administrative expenses

 
3,193

 
5,869

 
9,242

Research and development expenses

 
3,662

 
4,891

 
10,615

Restructuring and contract termination charges, net

 
(53
)
 

 
568

Income from discontinued operations before income taxes
$

 
$
5,447

 
$
650

 
$
18,564



The table below provides a reconciliation of the carrying amounts of the major classes of assets and liabilities of the discontinued operations to the amounts presented separately in the consolidated balance sheets at October 1, 2017 and January 1, 2017.
 
October 1,
2017
 
January 1,
2017
 
(In thousands)
Current assets of discontinued operations:
 
 
 
Accounts receivable
$

 
$
28,400

Inventories

 
26,977

Prepaid income taxes


 
425

Other current assets

 
3,183

Total current assets of discontinued operations

 
58,985

Property, plant and equipment, net

 
25,219

Intangible assets

 
3,292

Goodwill

 
38,794

Other assets, net

 
1,084

Long-term assets of discontinued operations

 
68,389

Total assets of discontinued operations
$

 
$
127,374

 
 
 
 
Current liabilities of discontinued operations:
 
 
 
Accounts payable
$

 
$
16,770

Accrued restructuring and contract termination charges

 
209

Accrued expenses and other current liabilities
2,154

 
9,992

Total current liabilities of discontinued operations

2,154

 
26,971

Deferred income taxes

 
7,851

Long-term liabilities

 
7,109

Total long-term liabilities

 
14,960

Total liabilities of discontinued operations
$
2,154

 
$
41,931